Apolipoprotein M: Research Progress and Clinical Perspective

Area of Science:

• Lipid metabolism and cardiovascular research
• Biochemistry and molecular biology
• Atherosclerosis and lipoprotein research

Background:

• Apolipoprotein M (apoM) is a 23 kDa protein belonging to the lipocalin superfamily.
• The human apoM gene is located on chromosome 6 within the major histocompatibility complex (MHC) class III locus.
• ApoM is primarily expressed in hepatocytes and kidney tubular epithelium.

Purpose of the Study:

• To investigate the role of apolipoprotein M (apoM) in high-density lipoprotein (HDL) metabolism and function.
• To explore the association of apoM with antiatherogenic properties of HDL.
• To elucidate the function of apoM as a carrier of sphingosine-1-phosphate (S1P).

Main Methods:

• Characterization of apoM structure and gene location.
• Analysis of apoM expression in human tissues.
• Investigation of apoM's presence in different lipoprotein classes in plasma.
• Assessment of apoM's role in HDL formation, particularly pre-beta HDL1.
• Evaluation of apoM's function as an S1P carrier in vivo.

Main Results:

• ApoM is critical for the formation of HDL, especially pre-beta HDL1.
• ApoM is mainly found on HDL particles in human plasma but can associate with triglyceride-rich lipoproteins.
• ApoM acts as a natural carrier of sphingosine-1-phosphate (S1P) in vivo.
• These findings suggest apoM contributes to HDL's antiatherogenic, endothelial protective, and anti-inflammatory effects.

Conclusions:

• Apolipoprotein M plays a vital role in HDL biogenesis and function.
• ApoM's ability to carry S1P links it to HDL's diverse protective mechanisms against atherosclerosis.
• Further research into apoM may reveal new therapeutic targets for cardiovascular diseases.